Methicillin-Susceptible Staphylococcus Aureus Market - Global Industry Analysis, Trends and Forecast 2014 – 2020

Submitted by: Submitted by

Views: 76

Words: 940

Pages: 4

Category: Business and Industry

Date Submitted: 07/15/2014 12:44 AM

Report This Essay

Methicillin-susceptible staphylococcus aureus (MSSA) infections are the infections caused by gram-positive bacterium. Staphylococcus aureus is the common pathogen in the skin, bone, central nervous system, pulmonary and soft tissues. These bacteria produce beta-lactamase which is the major cause of the infection. MSSA infection may lead to the skin allergies, pneumonia and endocarditis. Methicillin-susceptible staphylococcus aureus market is segmented on the basis of the treatment methods used for treating infections which are as follows:

Semi-synthetic penicillin (intravenous oxacillin, intravenous nafcillin, oral dicloxacilin)

Cephalosporins (oral cephalexin, intravenous cefazolin)

Vancomycin (vanocin)

Linezolid (Zyvox)

Daptomycin (Cubicin)

Browse Full Report with TOC: http://www.transparencymarketresearch.com/mssa-market.html

Semi synthetic penicillin captures the major share of the market followed by the cephalosporins. However Vancomycin is only used when patient is allergic to penicillin. In normal conditions, vancomycin is avoided because the rate of action of these drugs is slow in comparison to others and overuse of vancomycin leads to the development of vancomycin resistant staphylococcus aureus bacteria inside the body. Linezolid and Deptomycin are prescribed by the doctors when the MSSA leads to skin and soft tissue infection and pneumonia in children and adults.

Methicillin-susceptible staphylococcus aureus (MSSA) market is growing at faster pace majorly due to increasing rate of morbidity and mortality of the MSSA infection. Additionally, the extensive research and development activities with respect to the development of the more efficient and less time consuming drugs is also driving the market of methicillin-susceptible staphylococcus aureus. As for instance, a study performed at the John Radcliffe Hospital, Oxford, U.K., shows that MSSA infection has mortality rate of 27%. Therefore, there is an excessive need to develop novel...